15/11/2024  15:34:47 Var. +0.17 Volume Denaro15:37:54 Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
18.43USD +0.93% 102
Fatturato: 1,883.86
18.20Quantità in denaro: 200 -Quantità in lettera: - 199.94 mill.USD 27.08% 2.00

Descrizione business

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven provider of weight-loss and healthy living products and programs. Medifast aims to help customers lead a healthier lifestyle through a holistic approach to weight-loss and weight management, nutrition education and fitness. Medifast's proven results are based on the use of structured meal plans featuring Medifast Meals, which are nutritionally designed to assist customers with successful weight-loss and weight management. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. The company also offers sports nutrition products under the brand Dual Fuel™ Nutrition that are formulated to provide athletes and active individuals with the right balance of carbohydrates and high quality protein for top performance. Medifast was founded in 1980 and is located in Owings Mills, Maryland.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Daniel Chard
Consiglio di amministrazione
Jim Maloney, Claudia Greninger, Jason L. Groves, Esq., Nicholas Johnson, Tony Tyree
Consiglio di sorveglianza
Dan R. Chard, Andrea B. Thomas, Jeffrey J. Brown, Michael A. Hoer, Scott Schlackman, Elizabeth A. Geary, Ming Xian
 

Dati aziendali

Name: Medifast Inc.
Indirizzo: 100 International Drive,Baltimore, Maryland 21202, USA
Telefono: +1-410-581-8042
Fax: -
E-mail: -
Internet: www.medifast1.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: -

Rapporti con gli investitori

Name: Steven Zenker
IR telefono: +1-443-379-5256
IR Fax: -
IR e-mail: InvestorRelations@m...inc.com InvestorRelations@medifastinc.com

Principali azionisti

FreeFloat
 
65.90%
BlackRock, Inc.
 
14.70%
The Vanguard Group
 
10.70%
Renaissance Funds
 
8.70%